Search

Author/Creator Packman, Seymour

1. Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results. Issue 9 (11th July 2021)

Authors:
Mistry, Pramod K.; Lukina, Elena; Ben Turkia, Hadhami; Shankar, Suma P.; Baris Feldman, Hagit; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Lau, Heather; Petakov, Milan; Assouline, Sarit; Balwani, Manisha; Danda, Sumita; Hadjiev, Evgueniy; Ortega, Andres; Foster, Meredith C.; Gaemers, Sebastiaan...
Journal:
American journal of hematology
Issue:
Volume 96:Issue 9(2021)
Page Start:
1156
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trial. Issue 11 (3rd October 2017)

Authors:
Mistry, Pramod K.; Lukina, Elena; Ben Turkia, Hadhami; Shankar, Suma P.; Baris, Hagit; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Pastores, Gregory; Petakov, Milan; Assouline, Sarit; Balwani, Manisha; Danda, Sumita; Hadjiev, Evgueniy; Ortega, Andres; Gaemers, Sebastiaan J. M.; Tayag, Regina; P...
Journal:
American journal of hematology
Issue:
Volume 92:Issue 11(2017:Nov.)
Page Start:
1170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. Issue 5 (20th March 2015)

Authors:
Germain, Dominique P; Charrow, Joel; Desnick, Robert J; Guffon, Nathalie; Kempf, Judy; Lachmann, Robin H; Lemay, Roberta; Linthorst, Gabor E; Packman, Seymour; Scott, C Ronald; Waldek, Stephen; Warnock, David G; Weinreb, Neal J; Wilcox, William R
Journal:
Journal of medical genetics
Issue:
Volume 52:Issue 5(2015)
Page Start:
353
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗